Completed PHASE4 INTERVENTIONAL 2-arm NCT03578276

Prophylactic Treatment: Lessdrops™ vs Standard Drops Regimen

Lessdrops™ Prophylactic Treatment After Routine Phacoemulsification Compared to Standard Drops Regimen

Sponsor: Carolina Eyecare Physicians, LLC

Conditions Cataract

Interventions Bromfenac 0.075% Oph Solution Gatifloxacin Ophthalmic Pred-Gati-Brom Prednisolone acetate 1% ophthalmic suspension

Updated 7 times since 2018 Last updated: Jun 9, 2022 Started: Jun 22, 2018 Primary completion: Dec 4, 2019 Completion: Dec 4, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03578276, this PHASE4 trial focuses on Cataract and remains completed. Sponsored by Carolina Eyecare Physicians, LLC, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jul 2022 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2022 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Feb 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Aug 2018 — Feb 2020 [monthly]

Recruiting PHASE4

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Carolina Eyecare Physicians, LLC
Imprimis Pharmaceuticals, Inc.
Science in Vision

Data source: Carolina Eyecare Physicians, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mt. Pleasant, United States